Lawson McLean Anna, Rosahl Steffen
Department of Neurosurgery, HELIOS Klinikum Erfurt, Nordhäuser Str. 74, 99089, Erfurt, Germany.
Acta Neurochir (Wien). 2016 Nov;158(11):2127-2134. doi: 10.1007/s00701-016-2927-9. Epub 2016 Sep 2.
To date, few studies have been published about the growth dynamics of tumors associated with neurofibromatosis type-2 (NF2), none of which evaluated gender-specific differences. Our aim was to compare radiographic data of female and male patients with NF2.
MR images of 40 patients (20 female, 20 male) from the regional NF2 referral center were included in this analysis. Tumor sizes were determined by semi-automated volumetric measurement. Intracranial tumors were measured on post-contrast T1-weighted MRI datasets and volumes of intramedullary spinal tumors were determined from sagittal T2-weighted MRI datasets.
The median follow-up time was 91 months (range, 16-199 months) per patient. Intracranial tumors: On average, female patients had 13.4 neoplasms, while male patients had 6.75 (p = 0.042). The overall median time to tumor progression of ≥20 % was 20 months for females and 18 months for males. Tumors of the cerebellopontine angle (CPA) that had undergone previous surgery had shorter progression-free intervals in females than in males (16 and 24 months, respectively; p = 0.012). The median 1-year growth rate was 17.5 ± 44.6 % in females compared to 12.5 ± 44.9 % in males (p = 0.625). Intramedullary spinal tumors: On average, females had 2.05 tumors and males had 1.75 tumors (p = 0.721). Median time to tumor progression was 21 months in females and 44 months in males (p = 0.204). After 2 years, the median growth rate was 24.4 ± 56.8 % in female and 13.5 ± 40.4 % in male patients (p = 0.813).
The radiographic data in this study suggest that female patients are affected by a greater number of tumors than male patients and that post-surgery tumors of the CPA grow faster in females than in males.
迄今为止,关于2型神经纤维瘤病(NF2)相关肿瘤生长动力学的研究报道较少,且均未评估性别差异。我们的目的是比较NF2女性和男性患者的影像学数据。
本分析纳入了来自地区NF2转诊中心的40例患者(20例女性,20例男性)的磁共振成像(MR)图像。通过半自动体积测量确定肿瘤大小。颅内肿瘤在增强后T1加权MRI数据集上进行测量,脊髓内肿瘤的体积从矢状面T2加权MRI数据集确定。
每位患者的中位随访时间为91个月(范围16 - 199个月)。颅内肿瘤:女性患者平均有13.4个肿瘤,而男性患者有6.75个(p = 0.042)。肿瘤进展≥20%的总体中位时间,女性为20个月,男性为18个月。既往接受过手术的桥小脑角(CPA)肿瘤,女性的无进展间期比男性短(分别为16个月和24个月;p = 0.012)。女性的中位1年生长率为17.5±44.6%,男性为12.5±44.9%(p = 0.625)。脊髓内肿瘤:女性平均有2.05个肿瘤,男性有1.75个肿瘤(p = 0.721)。肿瘤进展的中位时间女性为21个月,男性为4年个月(p = 0.204)。2年后,女性患者的中位生长率为24.4±%,男性患者为13.5±40.4%(p = 0.813)。
本研究中的影像学数据表明,女性患者比男性患者受更多肿瘤影响,且CPA术后肿瘤在女性中的生长速度比男性快。